#Handekzem: Direktvergleich von #Delgocitinib (ANZUPGO) und #Alitretinoin (TOCTINO u.a.)
Delgocitinib-Creme und Alitretinoin per os – zwei Reservemittel beim schweren chronischen Handekzem im Direktvergleich.
www.arznei-telegramm.de/html/2025_06...
Delgocitinib-Creme und Alitretinoin per os – zwei Reservemittel beim schweren chronischen Handekzem im Direktvergleich.
www.arznei-telegramm.de/html/2025_06...
Handekzem: Direktvergleich von ▼Delgocitinib (ANZUPGO) und Alitretinoin (TOCTINO u.a.)
Delgocitinib-Creme und Alitretinoin per os - zwei Reservemittel beim schweren chronischen Handekzem im Direktvergleich.
www.arznei-telegramm.de
June 25, 2025 at 8:48 AM
Everybody can reply
Weekly Roundup - PHARMA - 10 February 2025
www.linkedin.com/pulse/weekly...
kstrategyand.com/pharma-news
#Celltrion #Avtozma #Axsome #Symbravo #Anzupgo #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand
www.linkedin.com/pulse/weekly...
kstrategyand.com/pharma-news
#Celltrion #Avtozma #Axsome #Symbravo #Anzupgo #PharmaNews #Biotech #Pharma #Healthcare #ClinicalTrials #Humanteconomy #Humantec #KStrategyand
Weekly Roundup - PHARMA - 10 February 2025
🔊Celltrion’s Avtozma Wins FDA Approval for Autoimmune & Inflammatory Diseases Avtozma, an Actemra biosimilar, is approved in both IV and SC forms, backed by a Phase III trial confirming its similarity...
www.linkedin.com
February 12, 2025 at 4:22 AM
Everybody can reply
🧴 FDA approves #Anzupgo - first cream specifically for chronic hand eczema! Game-changer for 10% of Americans suffering from this painful condition when steroids fail. Targets JAK enzymes causing inflammation. #HandEczema #FDAApproval www.drugs.com/news/fda-app...
FDA Approves First Cream for Treating Chronic Hand Eczema, Anzupgo - Drugs.com MedNews
THURSDAY, July 24, 2025 The U.S. Food and Drug Administration (FDA) has signed off on the first-ever cream specifically approved for treating chronic hand eczem
www.drugs.com
July 24, 2025 at 7:13 PM
Everybody can reply
www.linkedin.com/pulse/leo-ph...
LEO Pharma’s Anzupgo® Gains MHRA Approval in Great Britain for Chronic Hand Eczema
#LEOPharma #ChronicHandEczema #AnzupgoCream #Delgocitinib #SkinHealth #NHSAccess #MedicalBreakthrough #HealthcareInnovation #Humanteconomy #Humantec
LEO Pharma’s Anzupgo® Gains MHRA Approval in Great Britain for Chronic Hand Eczema
#LEOPharma #ChronicHandEczema #AnzupgoCream #Delgocitinib #SkinHealth #NHSAccess #MedicalBreakthrough #HealthcareInnovation #Humanteconomy #Humantec
LEO Pharma’s Anzupgo® Gains MHRA Approval in Great Britain for Chronic Hand Eczema
LEO Pharma has secured marketing authorisation from the MHRA for its innovative treatment, Anzupgo® (delgocitinib) cream, marking a breakthrough for adults with moderate to severe Chronic Hand Eczema ...
www.linkedin.com
December 15, 2024 at 10:16 AM
Everybody can reply
New research on chronic hand #eczema! The FDA has approved ANZUPGO®, the first non-steroid cream just for moderate-to-severe chronic hand eczema. And in studies, Rinvoq improved chronic hand eczema up to 83% in 2 months. Learn more about this and other research news at: https://bit.ly/3JLOGXH
August 23, 2025 at 9:12 PM
Everybody can reply
🚨Breaking: @fda.gov approved Anzupgo, a JAK inhibitor and nonsteroidal option for moderate to severe chronic hand eczema.
🔑"Importantly, it fills a treatment gap for patients who might otherwise require systemic therapy," Melinda Gooderham told @gohealio.bsky.social
www.healio.com/news/dermato...
🔑"Importantly, it fills a treatment gap for patients who might otherwise require systemic therapy," Melinda Gooderham told @gohealio.bsky.social
www.healio.com/news/dermato...
FDA approves Anzupgo for chronic hand eczema
The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond to or cannot receive topical corticosteroids, Leo Pharma announced in a pre...
www.healio.com
July 24, 2025 at 5:20 PM
Everybody can reply
3 reposts
4 likes
Delgocitinib Cream (Anzupgo) for Chronic Hand Eczema - Read our free open-access article: medicalletter.org/anzup739b
#FOAMed
#FOAMed
October 6, 2025 at 3:41 PM
Everybody can reply
#dermatology #skindisease #MHRA #Anzupgo #delgocitinib #eczemacream #handeczema #chronichandeczema #LEOPharma #UKMHRA #topicalJAKinhibitor #JAKinhibitor #phase3clincialtrials #DELTA1clincialtrial #DELTA2clinicaltrial #DELTA3openlabelextensiontrial #NICE #NHS
pf-media.co.uk/news/mhra-gr...
pf-media.co.uk/news/mhra-gr...
MHRA grants marketing authorisation for LEO Pharma’s eczema cream - Pf Media
The MHRA has granted marketing authorisation for LEO Pharma’s cream for the treatment of patients with moderate to severe chronic hand eczema.
pf-media.co.uk
December 6, 2024 at 10:36 AM
Everybody can reply
New Hand Eczema Treatment Anzupgo (Delgocitinib) Gets FDA Okay – FROUSA Media - With the U.S. Food and Drug Administration (FDA) approval of Anzupgo (delgocitinib), adult
https://frousa.org/new-hand-eczema-treatment-anzupgo-delgocitinib-gets-fda-okay/
https://frousa.org/new-hand-eczema-treatment-anzupgo-delgocitinib-gets-fda-okay/
August 2, 2025 at 3:32 AM
Everybody can reply
The Janus kinase (JAK) inhibitor delgocitinib, marketed as Anzupgo by Leo Laboratories, has been launched and is now available in the UK on private prescription. Find out more on MIMS
buff.ly/BVmAaQP?
buff.ly/BVmAaQP?
In brief: Anzupgo launched to treat hand eczema
This site is intended for healthcare professionals
buff.ly
March 31, 2025 at 10:47 AM
Everybody can reply
La crème Anzupgo 20 mg/g est indiquée pour traiter les formes modérées à sévères d’eczéma chronique des mains chez l’adulte.
Eczéma des mains : du nouveau mais pas encore en pharmacie
La crème Anzupgo 20 mg/g est indiquée pour traiter les formes modérées à sévères d’eczéma chronique des mains chez l’adulte. Elle est utilisée en seconde intention, après les dermocorticoïdes. Anzupgo contient un nouvel inhibiteur des Janus...
www.lequotidiendupharmacien.fr
June 9, 2025 at 9:00 AM
Everybody can reply